Wells Fargo & Company Absci Corp Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Absci Corp stock. As of the latest transaction made, Wells Fargo & Company holds 31,270 shares of ABSI stock, worth $125,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,270
Previous 494
6229.96%
Holding current value
$125,080
Previous $2,000
4700.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ABSI
# of Institutions
121Shares Held
56.1MCall Options Held
190KPut Options Held
114K-
Redmile Group, LLC San Francisco, CA8.25MShares$33 Million1.66% of portfolio
-
Fred Alger Management, LLC New York, NY7.26MShares$29 Million0.11% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.34MShares$25.4 Million0.23% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$21.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.28MShares$17.1 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $371M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....